Cargando…
PT594. Placebo effects in Alzheimer Disease: analysis of the CATIE-AD data
Autores principales: | Ozawa, Chisa, Suzuki, Takefumi, Kishimoto, Taishiro, Yoshida, Kazunari, Nagai, Nobuhiro, Ohtani, Ai, Endo, Aki, Mimura, Masaru, Uchida, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616928/ http://dx.doi.org/10.1093/ijnp/pyw044.594 |
Ejemplares similares
-
PT567. Improvement to antipsychotic treatment at week 2 predicts subsequent treatment response in behavioral and psychological symptoms with dementia: Analysis of the CATIE-AD data
por: Yoshida, Kazunari, et al.
Publicado: (2016) -
Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey
por: Nagai, Nobuhiro, et al.
Publicado: (2020) -
PM398. Fluctuations in hallucinatory experiences within a day in relation to dopamine D2 receptor blockade with antipsychotics in patients with schizophrenia
por: Koizumi, Teruki, et al.
Publicado: (2016) -
Modification of the therapist’s facial expressions using virtual reality technology during the treatment of social anxiety disorder: a case series
por: Horigome, Toshiro, et al.
Publicado: (2023) -
Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder
por: Nomura, Kensuke, et al.
Publicado: (2021)